All In MedTech

FDA Clearance Tracker · P200020

SBL-3 Multifocal Intraocular Lens

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Jul 22, 2022 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Jul 22, 2022

Approved

Time to decision

858 days

Received Mar 16, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P200020
Device name
SBL-3 Multifocal Intraocular Lens
Applicant
Lenstec, Inc.
Applicant location
St. Petersburg, FL
Received
Mar 16, 2020
Decided
Jul 22, 2022
Decision
Approved
Supplements
11 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code MFK

FDA's approval statement

As written in FDA's record.

Approval for the Lenstec SBL-3 Multifocal Intraocular Lens. This Lenstec SBL-3 Multifocal Intraocular Lens is indicated for primary implantation for the visual correction of aphakia, in adult patients with 1 diopter or less of pre-existing corneal astigmatism, in whom a cataractous lens has been removed. The lens mitigates the effects of presbyopia by providing a bifocal correction. Compared to an aspheric monofocal IOL, the lens provides improved near visual acuity, while maintaining comparable distance and intermediate visual acuity. The lens promotes the less frequent use of vision correction choices at near distance (including glasses, contact lenses, magnifying glasses, and digital adjustments on electronic devices), compared to an aspheric monofocal IOL, as reported in patient-reported outcomes. The SBL-3 multifocal IOL is intended for capsular bag placement only.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MFK. The earliest in FDA's data is P960028, decided Sep 5, 1997.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Lenstec, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.